Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 109, Issue 10, Pages 2607-2618
Publisher
Springer Nature
Online
2013-10-16
DOI
10.1038/bjc.2013.643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent
- (2012) Jayasree S. Nair et al. CELL CYCLE
- Physiological and Oncogenic Aurora-A Pathway
- (2012) Toshiaki SAEKI et al. International Journal of Biological Sciences
- A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1(R) in Combination With Paclitaxel in Solid Tumors
- (2012) R. J. Kelly et al. ONCOLOGIST
- Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
- (2011) Enke Baldini et al. BMC CANCER
- Mechanisms of drug resistance in kinases
- (2011) Rina Barouch-Bentov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Copy number defects of G1-Cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis
- (2011) Jan J. Molenaar et al. GENES CHROMOSOMES & CANCER
- BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
- (2011) Chun Hei Antonio Cheung et al. PLoS One
- Aurora kinase inhibitors as anticancer molecules
- (2010) Hiroshi Katayama et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma
- (2010) Xiang-Bo Wan et al. CANCER BIOLOGY & THERAPY
- Emerging drugs for high-grade osteosarcoma
- (2010) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Functional genome screen for therapeutic targets of osteosarcoma
- (2009) Umio Yamaguchi et al. CANCER SCIENCE
- Novel strategies for reversing platinum resistance
- (2009) Mian M.K. Shahzad et al. DRUG RESISTANCE UPDATES
- The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survival
- (2009) Paul et al. Frontiers in Bioscience-Landmark
- Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort
- (2009) Laura Ottaviano et al. GENES CHROMOSOMES & CANCER
- Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicity
- (2009) Salvatore Ulisse et al. JOURNAL OF ENDOCRINOLOGY
- Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®
- (2008) Robert W. Robey et al. BIOCHEMICAL PHARMACOLOGY
- Overcoming Glutathione S-Transferase P1-Related Cisplatin Resistance in Osteosarcoma
- (2008) M. Pasello et al. CANCER RESEARCH
- Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro
- (2008) Patrick J. Messerschmitt et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines
- (2008) Y. Arlot-Bonnemains et al. ENDOCRINE-RELATED CANCER
- Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines
- (2008) Claudia M. Hattinger et al. GENES CHROMOSOMES & CANCER
- Aurora kinases as targets for cancer therapy
- (2007) Giannis Mountzios et al. CANCER TREATMENT REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now